NYSE:HQL

Tekla Life Sciences Investors

Stock

USD

Last Close

16.06

06/11 21:10

Market Cap

397.95M

Beta: 0.83

Volume Today

105.41K

Avg: 77.50K

Dividend Yield

9.13%

Payout:62.47%

Overview Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Sep '19	Sep '20	Sep '21	Sep '22	Sep '23
net income	-70.48M -	123.05M 274.60%	64.53M 47.56%	-104.60M 262.10%	22.35M 121.37%
depreciation and amortization
deferred income tax
stock based compensation
change in working capital
accounts receivables
inventory
accounts payables
other working capital
other non cash items	70.48M -	-123.05M 274.60%	-64.53M 47.56%	104.60M 262.10%	-22.35M 121.37%
net cash provided by operating activities
investments in property plant and equipment
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites
debt repayment
common stock issued
common stock repurchased
dividends paid
other financing activites
net cash used provided by financing activities
effect of forex changes on cash
net change in cash	1.12M -			-545 -	32 105.87%
cash at beginning of period	41 -	1.12M 2,739,260.98%		990 -	445 55.05%
cash at end of period	1.12M -	1.12M 0%		445 -	477 7.19%
operating cash flow
capital expenditure
free cash flow

All numbers in USD (except ratios and percentages)